glp 1 dementia prevention Could diabetes and weight loss drugs treat Alzheimer's disease? GLP-1 mimetics and cognition -
Description
Understanding tirzepatide results across clinical settings provides important context for evaluating safety data
doi: 10.1016/j.cgh.2024.03.006
2021;131(8):e148903
The ability of GLP-1s to "quiet the noise" in the reward circuit seems to extend beyond food
As self-regulating therapies, they possess built-in monitors of blood glucose, signalling to boost insulin secretion at times of high glucose and halting action as glucose levels fall below euglycaemic levels in response to insulin
[DOI] [PMC free article] [PubMed] [Google Scholar] 90.Bays HE, Kozlovski P, Shao Q, et al
